CompletedNot Applicable

Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.

Spain40 participantsStarted 2025-05-12

Plain-language summary

The goal of this observational study is to learn about the effects of anti-hair loss shampoo in subjects over the age of 18 who use shampoo to treat their hair loss caused by telogen effluvium (TE) and androgenetic alopecia (AGA). The main question it aims to answer is: • Does a shampoo use help to reduce the visible signs of hair loss related to TE and AGA? Subjects will use the shampoo for 3 months and visit the clinic for the visits established by the protocol.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Sex: Both (50% women; 50% men). * Age: 18-65 years. * Subjects with hair loss due to telogen effluvium or mild or incipient androgenic alopecia, in an 80/20 ratio. * Degree of androgenic alopecia: Ludwig scale score I-II for women and Hamilton-Norwood scale score III-II for men. * Telogen effluvium: Combing test. * Subjects with all hair types (oily, combination, sensitive, etc.). * Subjects with all scalp types (normal, sensitive, etc.). * Agree to participate voluntarily in the study and provide written informed consent. * Adequate level of understanding of the clinical study. * Good health (physical and mental). * Availability to attend visits to the research centres. * No application of any product to the experimental area on the first day of the trial. Exclusion Criteria: * Individuals under 18 years of age. * Pregnant or breastfeeding women. * Injuries or infection in the test area. * History of allergies to cosmetic products. * Known allergies to product components. * Sensitivity to any product component. * Patients who have undergone recent surgery or treatments in the study area. * Cancer patients. * Volunteers currently taking antibiotics, antihistamines, corticosteroids, beta-blockers, retinoids, azelaic acid, or acne therapies, or whose treatment ended within 15 days prior to the start of the study. Participation in another clinical study. * Use of or having used cosmetic products and/or oral or topical treatments for hair loss for at leas…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in hair lenght and thickness

Timeframe: From baseline to the end of use at 3 months.

Trial details

NCT IDNCT07433933

SponsorLacer S.A.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-10-16

View on ClinicalTrials.gov More Telogen Effluvium trials